دورية أكاديمية
Cancer disparities in Southeast Asia: intersectionality and a call to action.
العنوان: | Cancer disparities in Southeast Asia: intersectionality and a call to action. |
---|---|
المؤلفون: | Feliciano EJG; School of Medicine and Public Health, Ateneo de Manila University, Pasig City, Philippines.; Department of Medicine, NYC H+H/Elmhurst, Icahn School of Medicine at Mt. Sinai, Queens, NY, USA., Ho FDV; University of the Philippines College of Medicine, Manila, Philippines., Yee K; SingHealth Duke-NUS Global Health Institute, Singapore, Singapore., Paguio JA; Department of Medicine, Einstein Medical Center, Philadelphia, PA, USA., Eala MAB; University of the Philippines College of Medicine, Manila, Philippines.; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA., Robredo JPG; School of Medicine and Public Health, Ateneo de Manila University, Pasig City, Philippines.; Department of Global Health and Social Medicine, Harvard University, Boston, MA, USA., Ng K; Department of Medical Oncology, St Bartholomew's Hospital, Bart's Health NHS Trust, London, UK., Lim J; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Pyone KT; Radiation Oncology Department, Yangon General Hospital Yangon, Myanmar., Peralta CA; Harvard Business School, Boston, MA, USA., Flores JA; Department of Radiotherapy, Jose Reyes Memorial Medical Center, Manila, Philippines., Yao JS; Department of Medicine, Einstein Medical Center, Philadelphia, PA, USA., Santos PMG; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Ang CDU; Department of Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Surgery, University of Santo Tomas Hospital, Manila, Philippines., Lasco G; Development Studies Program, Ateneo de Manila University, Quezon City, Philippines.; Department of Anthropology, University of the Philippines Diliman, Quezon City, Philippines., Chan JSK; Cardio-oncology Research Unit, Cardiovascular Analytics Group, Hong Kong, China., Tse G; Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.; Kent and Medway Medical School, Canterbury, UK.; School of Nursing and Health Studies, Hong Kong Metropolitan University, Hong Kong, China., Tangco ED; Department of Radiation Oncology, The Medical City, Pasig City, Philippines., Kingham TP; Department of Surgical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Chitapanarux I; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand., Bhoo-Pathy N; Centre for Epidemiology and Evidence Based Practice, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Legaspi GD; Division of Neurosurgery, Department of Neurosciences, University of the Philippines Manila, Philippine General Hospital, Metro Manila, Philippines., Dee EC; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. |
المصدر: | The Lancet regional health. Western Pacific [Lancet Reg Health West Pac] 2023 Nov 18; Vol. 41, pp. 100971. Date of Electronic Publication: 2023 Nov 18 (Print Publication: 2023). |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101774968 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-6065 (Electronic) Linking ISSN: 26666065 NLM ISO Abbreviation: Lancet Reg Health West Pac Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: [London] : Elsevier Ltd., [2020]- |
مستخلص: | Competing Interests: KN has received personal fees from Pfizer, GSK and TESARO, Boehringer Ingelheim, travel grants from Conquer Cancer Foundation and research funding from Cancer Research UK. All other authors have no relevant conflict of interest to disclose. |
References: | Lancet. 2018 Jun 30;391(10140):2589-2591. (PMID: 30070211) Cancer Epidemiol. 2018 Jun;54:82-89. (PMID: 29684800) Lancet. 2017 May 6;389(10081):1841-1850. (PMID: 27916235) Lancet Reg Health West Pac. 2022 Oct 12;28:100615. (PMID: 36267226) Chin Clin Oncol. 2022 Dec;11(6):49. (PMID: 36632981) BMC Public Health. 2016 Mar 24;16:284. (PMID: 27009064) Lancet Reg Health West Pac. 2023 Oct 02;39:100933. (PMID: 37810419) PLoS One. 2014 Aug 11;9(8):e104917. (PMID: 25111507) PLoS One. 2012;7(2):e30995. (PMID: 22363531) N Engl J Med. 2021 Feb 4;384(5):474-480. (PMID: 33406325) Asia Pac J Clin Oncol. 2018 Oct;14(5):e543-e547. (PMID: 29316293) Asian Pac J Cancer Prev. 2020 Mar 01;21(3):577-582. (PMID: 32212781) Lancet. 2011 Jan 29;377(9763):429-37. (PMID: 21269685) Int J Environ Res Public Health. 2021 Jul 26;18(15):. (PMID: 34360179) Cancer. 2022 Aug 15;128(16):3013-3015. (PMID: 35713589) BMJ Glob Health. 2017 Mar 9;2(2):e000213. (PMID: 28589024) Lancet Reg Health West Pac. 2023 Jan 06;32:100667. (PMID: 36785859) iScience. 2023 Jun 14;26(7):107110. (PMID: 37456827) JCO Glob Oncol. 2022 Nov;8:e2200138. (PMID: 36332171) AIDS Behav. 2011 Apr;15(3):650-8. (PMID: 21104008) CA Cancer J Clin. 2021 May;71(3):209-249. (PMID: 33538338) Medicine (Baltimore). 2018 Mar;97(10):e9898. (PMID: 29517698) Cancer Control. 2019 Jan-Dec;26(1):1073274819863802. (PMID: 31319695) JCO Glob Oncol. 2021 Jun;7:901-916. (PMID: 34129359) Semin Radiat Oncol. 2017 Apr;27(2):176-183. (PMID: 28325245) Asian Pac J Cancer Prev. 2013;14(9):5435-40. (PMID: 24175839) |
معلومات مُعتمدة: | P30 CA008748 United States CA NCI NIH HHS |
تواريخ الأحداث: | Date Created: 20231206 Latest Revision: 20240210 |
رمز التحديث: | 20240210 |
مُعرف محوري في PubMed: | PMC10694578 |
DOI: | 10.1016/j.lanwpc.2023.100971 |
PMID: | 38053740 |
قاعدة البيانات: | MEDLINE |
كن أول من يترك تعليقا!